Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000421

Drug Information
Synonyms2-({6-[(3r)-3-Aminopiperidin-1-Yl]-3-Methyl-2,4-Dioxo-3,4-Dihydropyrimidin-1(2h)-Yl}methyl)benzonitrile; MolPort-005-933-065; CHEMBL376359; 850649-61-5; CID11450633; UNII-JHC049LO86; Alogliptin
IndicationDiabetes mellitus
[ICD9: 250   ICD10: E08-E13]
Phase III    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N    
CAS NumberCAS 850649-61-5
PubChem Compound IDCID 11450633.
PubChem Substance IDSID 16549582.
SuperDrug ATC IDA10BH04
TargetDipeptidyl peptidase 4 Inhibitor[1][2][3]
Ref 1Takeda. Product Development Pipeline. July 31 2009. To Reference
Ref 2Combining a dipeptidyl peptidase-4 inhibitor, alogliptin, with pioglitazone improves glycaemic control, lipid profiles and beta-cell function in db/db mice. Br J Pharmacol. 2009 Jun;157(3):415-26. Epub 2009 Apr 3. To Reference
Ref 3Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of Type 2 Diabetes. Curr Drug Targets. 2009 Jan;10(1):71-87. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543